The Latest Breaking News from Merck

March S&P 500 E-Mini futures (ESH25) are down -0.01%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.08% this morning as investors awaited the latest reading on U.S. job openings, comments from Federal Reserve officials, and corporate earnings reports from heavyweight names.

President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV vaccine manufacturer.

Biotech stocks will need to brace for political "games" Wednesday as the Senate meets to potentially confirm RFK Jr. to lead HHS.

Robert F. Kennedy, Jr. faces potential conflicts of interest as HHS secretary nominee due to financial ties with law firms handling litigation against drug...

President-elect Donald Trump's pick to lead HHS has a long history of discounting and peddling misinformation about the HPV vaccine.

Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock a sell?

Analysts at Miramar Capital are advising investors to sell “Magnificent 7” and instead invest in lower-valuation, dividend-paying healthcare stocks.

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second presidency.

Looking for some truly wowing profit growth from S&P 500 companies. A few are likely to knock your socks off.

Tragic death of Debrina Kawam in New York subway fire highlights safety concerns and the need for increased support services for vulnerable populations.

The Dow's biggest losers include companies in the aerospace, biopharma, and sports apparel sectors.